ReviewExperimental and clinical psychopharmacology2025
Overviewing the exponential model of demand and introducing a simplification that solves issues of span, scale, and zeros.
Review in Experimental and clinical psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Twenty-five years of simulated demand: A bibliometric and systematic review of hypothetical drug purchase tasks.Journal of the experimental analysis of behavior · 2026Pooled it
- Comparing current veterans affairs contingency management incentive structures against common alternatives on intentions to abstain from alcohol among veterans.Experimental and clinical psychopharmacology · 2026Article
- Applying the reinforcer pathology model to alcohol use and suicide risk: An initial test.Journal of the experimental analysis of behavior · 2026Article
- Identification and management of nonsystematic cross-commodity data: Toward best practice.Experimental and clinical psychopharmacology · 2026Article
- Preclinical abuse potential testing using behavioral economics and drug self-administration demand-curve analysis: A strategy to improve resolution of drug stratification for regulatory control.Pharmacological reviews · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
One of the most successful models of describing the decay in commodity consumption as a function of cost across multiple domains is the exponential model introduced by Hursh and Silberberg (2008). This model formulates the value of a commodity by including a "standardized price" adjustment. This adjustment allows for a theoretically scale-invariant parameter to estimate a normalized decay (α, the sensitivity to changes in price) in commodity consumption that was detangled from an organism's consumption when a commodity is free (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.